Concord Biotech IPO vs Yatharth Hospital IPO

Comparision between Concord Biotech IPO and Yatharth Hospital IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Yatharth Hospital IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	Yatharth Hospital IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	Intensive Fiscal Services Private Limited Ambit Private Limited Iifl Securities Ltd
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Yatharth Hospital IPO is up to ₹686.55 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Yatharth Hospital IPO is ₹300.00 per share.

	Concord Biotech IPO	Yatharth Hospital IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹705.00 per share	₹285.00 per share
Issue Price (Upper)	₹741.00 per share	₹300.00 per share
Issue Price (Final)	₹741.00 per share	₹300.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share
Market Lot Size	20 shares	50 shares
Fresh Issue Size		1,63,33,333 shares
Fresh Issue Size (Amount)		up to ₹490.00 Cr
OFS Issue Size	2,09,25,652 shares	65,51,690 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr	up to ₹196.55 Cr
Issue Size Total	2,09,25,652 shares	2,28,85,023 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹686.55 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Yatharth Hospital IPO opens on Jul 26, 2023. The closing date of Concord Biotech IPO and Yatharth Hospital IPO is Aug 08, 2023, and Jul 28, 2023, respectively.

	Concord Biotech IPO	Yatharth Hospital IPO
Anchor Bid Date	Aug 03, 2023	Jul 25, 2023
Issue Open	Aug 04, 2023	Jul 26, 2023
Issue Close	Aug 08, 2023	Jul 28, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Aug 02, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Aug 03, 2023
Credit of Share (Tentative)	Aug 17, 2023	Aug 04, 2023
Listing date (Tentative)	Aug 18, 2023	Aug 07, 2023
Anchor Lockin End date 1	Sep 10, 2023	Sep 01, 2023
Anchor Lockin End date 2	Nov 09, 2023	Oct 31, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Yatharth Hospital IPO P/E ratio of 39.16.

Concord Biotech IPO

Yatharth Hospital IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

Yatharth Hospital IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2019	31 Mar 2020	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	256.56	287.20	308.77	426.02	485.97
Revenue	102.07	146.18	229.19	402.59	523.10
Profit After Tax	3.98	-2.05	19.59	44.16	65.77
Net Worth	55.60	54.29	72.46	116.89	182.96
Reserves and Surplus
Total Borrowing	164.57	184.57	186.11	258.19	263.78

Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

91.34%

Promoter Shareholding (Post-Issue)

44.08%

66.32%

P/E Ratio

32.29

39.16

Market Cap

₹7752.06 Cr.

₹2575.51 Cr.

ROE

20.06%%

35.95%%

ROCE

24.27%%

26.10%%

Debt/Equity

1.44

EPS

₹20.79

₹10.09

RoNW

20%%

35.95%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Yatharth Hospital IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 45,77,004 shares in Yatharth Hospital IPO.

	Concord Biotech IPO	Yatharth Hospital IPO
Anchor Investor Reserveration	62,74,695 shares	68,65,506 shares
Market Maker Reserveration
QIB	41,83,130 shares	45,77,004 shares
NII	31,37,348 shares	34,32,754 shares
RII	73,20,479 shares	80,09,759 shares
Employee	10,000 shares	0 shares
Others
Total	1,46,50,957 shares	1,60,19,517 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Yatharth Hospital IPO subscribed 37.28x.

	Concord Biotech IPO	Yatharth Hospital IPO
QIB (times)	67.67x	86.37x
NII (times)	16.99x	38.62x
Big NII (times)	19.30x	41.76x
Small NII (times)	12.37x	32.34x
RII (times)	3.78x	8.66x
Employee (times)	24.48x
Other (times)
Total (times)	24.87x	37.28x

Compare with others

Concord Biotech IPO	Yatharth Hospital IPO
Aeroflex Industries IPO	India Shelter Finance IPO
Pyramid Technoplast IPO	Balaji Speciality Chemicals IPO
India Shelter Finance IPO	TVS Supply Chain Solutions IPO
Balaji Speciality Chemicals IPO	Concord Biotech IPO
TVS Supply Chain Solutions IPO	SBFC Finance IPO
SBFC Finance IPO	Netweb Technologies India IPO
Yatharth Hospital IPO	Utkarsh Small Finance Bank IPO
Netweb Technologies India IPO	Senco Gold IPO
Utkarsh Small Finance Bank IPO	Cyient DLM IPO
Senco Gold IPO	ideaForge Technology IPO

Comments

Add a public comment...